Scientific Due Diligence
Scientific due diligence is the key for pharmaceutical assets being in or out-licensed and we offer
just that, from assessment of the mode of action to an informed SWOT analysis
Robustness of SAR of the lead series of the asset
Leveraging versatile workflows, our molecular similarity engine, interaction fingerprints database and bioactive conformations database for a comprehensive due diligence
Data availability, potential issues with data, mode of action, IVIVC, pharmacokinetics, selectivity and a host of other parameters will be benchmarked against competition
Partner with other companies based on the need to run key experiments required for due diligence
Extensive SWOT analysis detailing the asset quality